Skip to main content
Veterinary Medicines

Versifel FeLV, suspension for injection

Authorised
  • Feline leukemia virus, strain Kawakami-Theilen, Inactivated

Product identification

Medicine name:
Versifel FeLV, suspension for injection
Versifel FeLV Suspensie voor injectie
Versifel FeLV Suspension injectable
Versifel FeLV Injektionssuspension
Active substance:
  • Feline leukemia virus, strain Kawakami-Theilen, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline leukemia virus, strain Kawakami-Theilen, Inactivated
    8.10
    log2 geometric mean titre
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA01
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • (ID2): 1 Box with 25 Bottle (Glass) with 1 Dose (25 Dose)
  • (ID1): 1 Box with 10 Bottle (Glass) with 1 Dose (10 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V429432
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0254/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022

Combined File of all Documents

English (PDF)
Published on: 20/10/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."